Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine, 5-FU, and Radiation Boost for Cholangiocarcinoma
NCT00983541Phase 2Terminated
- Sponsor
- University of Utah
- Start
- Sep 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, fluorouracil in cholangiocarcinoma (CCA), sponsored by University of Utah. Started Sep 2009; status: terminated.
02
Drugs
gemcitabinefluorouracil
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on NCT00983541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00983541.